Symbrachydactyly of hands and feet

disease
On this page

Also known as De Smet-Fabry-Fryns syndromefrints de Smet Fabry Fryns syndromesymbrachydactyly of the hand and foot

Summary

Symbrachydactyly of hands and feet (MONDO:0015516) is a disease. A subtype of non-syndromic brachydactyly — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 8

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families2WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

8 HPO clinical features (Orphanet curated; top 8 by frequency):

HPO IDTermFrequency
HP:0009800Maternal diabetesVery frequent (80-99%)
HP:0100745Abnormality of the humeroulnar jointVery frequent (80-99%)
HP:0002650ScoliosisFrequent (30-79%)
HP:0003422Vertebral segmentation defectFrequent (30-79%)
HP:0006501Aplasia/Hypoplasia of the radiusFrequent (30-79%)
HP:0009601Aplasia/Hypoplasia of the thumbFrequent (30-79%)
HP:0040071Abnormal morphology of ulnaFrequent (30-79%)
HP:0031095Abnormal humerus morphologyFrequent (30-79%)

Identifiers

Disease identifiers

FieldValue
Canonical namesymbrachydactyly of hands and feet
Mondo IDMONDO:0015516
MeSHC538062
Orphanet1570
ICD-11159463685
UMLSC2931719
MedGen419146
GARD0001680
Is cancer (heuristic)no

Also known as: De Smet-Fabry-Fryns syndrome · frints de Smet Fabry Fryns syndrome · symbrachydactyly of the hand and foot

Disease family

An umbrella term covering 2 Mondo subtypes.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseasebrachydactyly › non-syndromic brachydactyly › symbrachydactyly of hands and feet

Related subtypes (2): non-syndromic brachydactyly of fingers, non-syndromic brachydactyly of toes

Subtypes (2): symbrachydactyly of hand and foot, unilateral, symbrachydactyly of hand and foot, bilateral

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.